pLN379 (FuGW-S(E2F1)p-mKate2)
(Plasmid
#105177)
-
Purposesynthetic promoter E2F1 drives mKate2 expression
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 105177 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneFUGW
- Backbone size w/o insert (bp) 9000
-
Vector typeMammalian Expression, Lentiviral, Synthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameS(E2F1)p-mKate2
-
SpeciesSynthetic
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLN379 (FuGW-S(E2F1)p-mKate2) was a gift from Timothy Lu (Addgene plasmid # 105177 ; http://n2t.net/addgene:105177 ; RRID:Addgene_105177) -
For your References section:
Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy. Nissim L, Wu MR, Pery E, Binder-Nissim A, Suzuki HI, Stupp D, Wehrspaun C, Tabach Y, Sharp PA, Lu TK. Cell. 2017 Nov 16;171(5):1138-1150.e15. doi: 10.1016/j.cell.2017.09.049. Epub 2017 Oct 19. 10.1016/j.cell.2017.09.049 PubMed 29056342